UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2026	Dec. 31, 2025
Current assets
Cash and cash equivalents	$ 6,365,624	$ 8,705,218
Prepaid expenses and other current assets	916,956	1,086,121
Deferred financing costs	0	99,305
Total current assets	7,282,580	9,890,644
Operating lease right-of-use assets	144,331	170,733
Total assets	7,426,911	10,061,377
Current liabilities
Accounts payable	2,278,619	3,435,297
Accrued expenses and other current liabilities	1,038,731	995,290
Related party payable	147,223	116,476
Operating lease liability, current	145,456	145,456
Debentures	2,343,778	5,245,543
Total current liabilities	5,953,807	9,938,062
Loan payable	21,042	25,865
Operating lease liability, non-current	24,168	60,139
Total liabilities	5,999,017	10,024,066
Commitments and contingencies
Shareholders' equity
Common shares, no par value; 39,995,463 and 25,176,303 shares authorized, issued and outstanding at March 31, 2026 and December 31, 2025, respectively	67,114,012	57,076,175
Common shares to be issued	313,934	313,934
Additional paid-in capital	7,478,881	6,879,575
Accumulated other comprehensive income	(190,510)	10,880
Accumulated deficit	(73,390,261)	(64,348,118)
Total shareholders' equity attributable to Medicus Pharma Ltd.	1,326,056	(67,554)
Non-controlling interests	101,838	104,865
Total shareholders' equity	1,427,894	37,311
Total liabilities and shareholders' equity	$ 7,426,911	$ 10,061,377